University of Texas Partnership
Graftworks holds exclusive rights from McGovern Medical School at University of Texas-Houston for patented tissue processing automation. This partnership is the foundation of our technology, our regulatory strategy, and our clinical validation pathway.
Exclusive Rights Agreement
McGovern Medical School at University of Texas-Houston developed the foundational IP for automated cord tissue harvesting. Graftworks holds the exclusive commercial rights to manufacture and distribute devices based on these patented methods.
This arrangement bridges world-class academic research in regenerative medicine with commercial-scale manufacturing — ensuring that breakthrough science reaches the patients who need it.
Three Issued U.S. Patents
Our patent portfolio covers both the devices and methods for automated cord tissue processing, providing a durable and sustainable competitive advantage model for our partners.
Device and method for tissue processing automation
Mechanical vessel stripping and tissue isolation
Precision graft harvesting methods
Interested in Partnering?
We're actively building partnerships with cord blood banks, tissue manufacturers, and healthcare suppliers.